CFOR
CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.06 | $0 | -$363,830 |
| 2025 Q4 | 2.08 | $26M | -$204,939 |
| 2025 Q3 | -0.06 | $0 | -$333,348 |
| 2025 Q2 | 0.35 | $4M | -$447,465 |
| 2025 Q1 | -0.04 | $0 | -$197,872 |
| 2024 Q4 | 0.42 | $5M | -$232,236 |
| 2024 Q3 | 1.43 | $0 | -$3M |
| 2024 Q2 | -1.18 | $28,000 | -$720,212 |